Potential Payments upon Termination or Change in Control
In February 2020, the compensation committee approved a restated severance and change in control agreement, or Severance and Change in Control Agreement, which has been entered into by each of our named executive officers and provides for each named executive officer to receive the benefits described below upon either a termination by us of the executive officer’s employment without “cause” or a voluntary resignation by the executive officer from his or her employment with “good reason” (each as defined in the Severance and Change in Control Agreement). We refer to either of these terminations as a “qualifying termination.” The terms and conditions of the Severance and Change in Control Agreement are substantially the same as the prior severance and change in control agreements, except that if a qualifying termination occurs during the change in control period, the named executive officer will additionally be entitled to one hundred percent of his or her annual target bonus opportunity at the rate in effect when the qualifying termination occurred or when the change in control occurred, whichever is greater. These benefits are contingent upon the executive officer executing a customary release of claims.
The benefits provided under the Severance and Change in Control Agreements vary depending on whether the executive officer is subject to the qualifying termination within a period beginning three months before a change in control (as defined in the Severance and Change in Control Agreement) and ending 12 months after a change in control, or the “change in control period”.
If a qualifying termination occurs prior to or after the change in control period, each of Messrs. Anderson, Rubin, Knudsen and Lal will be entitled to: (i) 12 months’, nine months’, nine months’ and nine months’ of continued payment of base salary, respectively, and (ii) if the executive officer elects to continue his or her health insurance coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985, or COBRA, then payment of the premiums for his or her continued health insurance (or equivalent cash payment, if applicable law so requires) for up to 12 months, nine months, nine months and nine months, respectively.
If a qualifying termination occurs during the change in control period, Messrs. Anderson, Rubin, Knudsen and Lal will be entitled to: (i) 18 months’, 12 months’, 12 months’ and 12 months’ continued payment of base salary, respectively, (ii) if the executive officer elects to continue his or her health insurance coverage under COBRA, then payment of the premiums for his or her continued health insurance (or equivalent cash payment, if applicable law so requires) for up to 18 months, 12 months, 12 months and 12 months, respectively, (iii) full acceleration of each of the executive officer’s then-outstanding but unvested equity awards, except that awards subject to the satisfaction of performance criteria would accelerate if, and only to the extent, set forth in the applicable award agreement, and (iv) one hundred percent of his or her annual target bonus opportunity at the rate in effect when the qualifying termination occurred or when the change in control occurred, whichever is greater. These benefits and acceleration are contingent upon the consummation of the change in control.
If a change in control occurred and our successor or acquirer refused to assume, convert, replace or substitute the then-outstanding and unvested equity awards held by the eligible named executive officers, then those awards would accelerate in full, except that awards subject to the satisfaction of performance criteria would accelerate if, and only to the extent, set forth in the applicable award agreement.
The Severance and Change in Control Agreements with the named executive officers are in effect for two years, unless renewed, or earlier terminated, subject to certain limitations. Except with respect to Mr. Stoecker and Mr. Jones, the benefits under the Severance and Change in Control Agreements supersede all other agreements and understandings between us and the named executive officers with respect to severance and vesting acceleration.
Mr. Stoecker’s Severance and Change in Control Agreement terminated in full on December 31, 2020. Prior to its termination, Mr. Stoecker was eligible for benefits of the same type and in the same amounts as those for Mr. Anderson, as described above, pursuant to his Severance and Change in Control Agreement. Under the terms of Mr. Stoecker’s October 2020 services agreement, in his capacity as Executive Chairman, Mr. Stoecker did not receive any severance in connection with his resignation as Chief Executive Officer, he waived his ability to terminate for “good reason” after October 5, 2020, and agreed to the termination of his Severance and Change in Control Agreement on December 31, 2020. If, after December 31, 2020, we terminate Mr. Stoecker’s employment as Executive Chairman without cause not within 12 months following a change in control, Mr. Stoecker shall only be entitled to earned but unpaid accrued compensation and reimbursement of unpaid expenses. If we (or our successor) terminate Mr. Stoecker’s employment as Executive Chairman without cause and within 12 months following a change in control, Mr. Stoecker shall be entitled to any earned but unpaid accrued compensation and reimbursement of unpaid expenses, and all of his outstanding and unvested stock options and RSUs shall immediately vest. Moreover, in the event a change in control occurs, and at such time